WebHeader_Grove.png
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations
Donate your vehicle and help support local, independent journalism today!

U.S. To Resume J&J COVID Vaccinations Despite Rare Clot Risk

Vaccine shot
Todd Bookman / NHPR
/
A COVID-19 vaccine dose prepared by a N.H. National Guard member.

U.S. health officials have lifted an 11-day pause on Johnson & Johnson vaccinations following a recommendation by an expert panel.

Advisers to the Centers for Disease Control and Prevention said Friday the benefits of the single-dose COVID-19 shot outweigh a rare risk of blood clots.

The CDC and Food and Drug Administration decided that J&J's vaccine is critical to fight the pandemic — and that the small clot risk could be handled with warnings to help younger women decide if they should use that shot or an alternative.

European regulators earlier this week made a similar decision, deciding the clot risk was small enough to allow rollout.

You make NHPR possible.

NHPR is nonprofit and independent. We rely on readers like you to support the local, national, and international coverage on this website. Your support makes this news available to everyone.

Give today. A monthly donation of $5 makes a real difference.